According to a new report published by Allied Market Research, titled, "Radiopharmaceuticals Market by End User, Radioisotope, Application, and Type: Global Opportunity Analysis and Industry Forecast, ...
Some people can’t enjoy caffeine without experiencing negative side effects. Learn about caffeine sensitivity risk factors, plus buzzy alternatives to consider.
Half-Life 3 appears closer to reality than ever. Dataminers have found fresh HLX references in Deadlock updates, developers are reportedly shifting to other projects as the game enters content lock, ...
When an electron travels through a polar crystalline solid, its negative charge attracts the positively charged atomic cores, causing the surrounding crystal lattice to deform. The electron and ...
According to Precedence Research, the global radiopharmaceutical CDMO market size is predicted to surpass around USD 8.50 ...
Despite being riddled with impurities and defects, solution-processed lead-halide perovskites are surprisingly efficient at ...
The ability to experience love at first sight rests on a cognitive skill you might not even realize you have: Humans are incredibly good at quickly assessing other people. “In less than seven seconds, ...
New data from major dark-energy observatories suggest the universe may not expand forever after all. A Cornell physicist calculates that the cosmos is heading toward a dramatic reversal: after ...
To store heat for days, weeks, or months, you need to trap the energy in the bonds of a molecule that can later release heat on demand. The approach to this particular chemistry problem is called ...
There's a reason why blacksmiths fire metals before hammering them. Heat always softens metal, making it more malleable and easier to reshape. Or does it? In a surprising new study, Northwestern ...
NASA gears up for a historic lunar flyby, AI gives stroke patients hope, and researchers discover the oldest known cave art What’s on the road to the launch of NASA’s Artemis II, how scientists are ...
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial ...